Deltyba Europska Unija - hrvatski - EMA (European Medicines Agency)

deltyba

otsuka novel products gmbh - Деламанид - tuberkuloza, višestruko otporna - antimikobakterija - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 i 5. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

MIOZAC 250 mg/20 mL rastvor za infuziju Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

miozac 250 mg/20 ml rastvor za infuziju

doo ˝farmacija 2011˝ bihać - добутамин - rastvor za infuziju - 250 mg/20 ml - 1 bočica sa rastvorom za infuziju sadrži: 250 mg dobutamina (što odgovara 280,28 mg dobutamin hidrohlorida)

Breyanzi Europska Unija - hrvatski - EMA (European Medicines Agency)

breyanzi

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastična sredstva - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

HUMICARE 200 I HUMICARE 180 Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

humicare 200 i humicare 180

medial d.o.o., zagreb - sustav za grijanje i ovlaživanje medicinskih respiratornih plinova